US Patent Issued to GUANGZHOU BIO-GENE TECHNO on Nov. 3 for "Chimeric antigen receptor fusion protein co-expressing IL-7 and CCR2b, and application thereof" (Chinese Inventors)

ALEXANDRIA, Va., Nov. 3 -- United States Patent no. 12,778,984, issued on Nov. 3, was assigned to GUANGZHOU BIO-GENE TECHNO (Guangzhou, China).

"Chimeric antigen receptor fusion protein co-expressing IL-7 and CCR2b, and application thereof" was invented by Guangchao Li (Guangzhou, China), Min Luo (Guangzhou, China), Wen Ding (Guangzhou, China) and Xuejun Wang (Guangzhou, China).

According to the abstract* released by the U.S. Patent & Trademark Office: "A chimeric antigen receptor fusion protein co-expressing IL-7 and CCR2b, and application thereof are provided. The fusion protein includes a chimeric antigen receptor, a 2A peptide, IL-7, a 2A peptide and CCR2b which are sequentially linked in series."

The patent was filed on March 30, 20...